Sponsored diagnostic testing programs for Primary Hyperoxaluria Type 1 (PH1)
Primary Hyperoxaluria Type 1 (PH1) is a rare inherited disorder in which a defect in the AGXT gene causes the body to overproduce oxalate. Excess oxalate combines with calcium to form crystals that can damage the kidneys and other organs. Early diagnosis is important because targeted therapies are available.
2 programs found for Primary Hyperoxaluria Type 1 (PH1)
The Alnylam Act® program offers complimentary gene‐panel testing and genetic counseling for patients with suspected PH1 (AGXT, GRHPR, HOGA1). The program supports you in confirming diagnosis, guiding patient care and referral, and facilitating family risk assessment. All testing and counseling services are provided at no cost to patients, providers, or payers.
The Alnylam Act® program offers complimentary 45-gene panel testing and genetic counseling for patients with suspected PH1 or a relevant family history (covering AGXT, GRHPR, HOGA1 and additional nephrolithiasis-associated genes). This expanded panel aids you in distinguishing PH1 from related conditions, supporting diagnosis, management pathways and family screening. All services are provided at no charge to the patient, provider or payer.
